ATS Medical strengthens cash position with restructured deal
This article was originally published in Clinica
Executive Summary
Mechanical heart valve company ATS Medical, which is suffering from a difficult cash situation, has restructured its supply deal with Centerpulse company Carbomedics in a move which "significantly improves [its] cash situation going into the future". It will also allow ATS to fund operations through the foreseeable future from existing sources of capital, according to the company's CEO, Richard Kramp.